◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

PharmaCorp Rx Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 4.8M 4.4M 4.0M 4.4M 1.1M
Operating Revenue 4.7M 4.3M 4.0M 4.4M 1.1M
Cost Of Revenue 2.8M 2.6M 2.4M 2.7M 688,999
Gross Profit 2.0M 1.7M 1.6M 1.7M 415,424
Selling General And Administration 2.2M 1.9M 1.2M 1.1M 1.5M
General And Administrative Expense 2.2M 1.9M 1.2M 1.1M 1.5M
Depreciation And Amortization In Income Statement 222,331 188,639 187,459 191,563 75,883
Operating Expense 2.5M 2.1M 1.4M 1.3M 1.5M
Operating Income -498,816 -330,682 228,166 358,167 -1.1M
EBIT -408,277 -214,524 375,735 630,599 -963,140
Interest Expense 19,803 13,245 13,706 14,396 13,653
Interest Expense Non Operating 19,803 13,245 13,706 14,396 13,653
Interest Income 56,182 83,415 104,328 191,499 151,083
Interest Income Non Operating 56,182 83,415 104,328 191,499 151,083
Net Interest Income 36,379 70,170 90,622 177,103 137,430
Other Income Expense 34,357 32,743 43,241 80,933 1,200
Other Non Operating Income Expenses 34,357 32,743 43,241 80,933 1,200
Pretax Income -428,080 -227,769 362,029 616,203 -976,793
Tax Provision -18,902 157,958 107,730 -107,030 828.00
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -427,516 -384,069 241,913 721,210 -975,861
Net Income From Continuing Operation Net Minority Interest -427,516 -384,069 241,913 721,210 -975,861
Net Income Including Noncontrolling Interests -409,178 -385,727 254,299 723,233 -977,621
Minority Interests -18,339 1,656 -12,386 -- 1,760
Net Income Common Stockholders -427,516 -384,069 241,913 721,210 -975,861
Net Income -427,516 -384,069 241,913 721,210 -975,861
EBITDA -185,946 -25,885 563,194 822,162 -887,257
Normalized EBITDA -185,946 -25,885 563,194 822,162 -887,257
Reconciled Depreciation 222,331 188,639 187,459 191,563 75,883
Basic EPS 0.00 0.00 0.00 -- -0.01
Diluted EPS 0.00 0.00 0.00 -- -0.01
Basic Average Shares 117.3M 117.3M 117.3M -- 113.2M
Diluted Average Shares 117.3M 117.3M 125.2M -- 113.2M
Tax Rate For Calcs 0.04 0.15 0.30 0.15 0.15
Normalized Income -427,516 -384,069 241,913 721,210 -975,861
Amortization -- -- 128,343 -- --
Amortization Of Intangibles Income Statement -- -- 128,343 -- --
Depreciation Amortization Depletion Income Statement 222,331 188,639 187,459 191,563 75,883
Depreciation Income Statement 222,331 188,639 59,116 230,121 75,883
Diluted NI Availto Com Stockholders -427,516 -384,069 241,913 721,210 -975,861
Net Income Continuous Operations -409,178 -385,727 254,299 723,233 -977,621
Net Non Operating Interest Income Expense 36,379 70,170 90,622 177,103 137,430
Other Gand A 901,996 721,086 379,760 700,859 359,545
Reconciled Cost Of Revenue 2.8M 2.6M 2.4M 2.7M 688,999
Salaries And Wages 1.3M 1.2M 828,630 419,685 1.1M
Total Expenses 5.3M 4.7M 3.8M 4.0M 2.2M
Total Operating Income As Reported -508,223 -336,032 222,601 352,218 -1.1M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 5.0M 9.6M 12.9M 12.9M 26.7M
Cash Cash Equivalents And Short Term Investments 5.0M 9.6M 12.9M 12.9M 26.7M
Cash Financial 5.0M 9.6M 12.9M 12.9M 26.7M
Accounts Receivable 785,928 643,163 372,437 326,783 222,516
Receivables 785,928 643,163 372,437 326,783 222,744
Inventory 2.5M 1.7M 1.6M 1.3M 329,368
Prepaid Assets 188,169 56,464 32,153 48,026 64,412
Current Assets 8.5M 12.0M 15.0M 14.6M 27.3M
Gross PPE 4.4M 4.1M 4.1M 4.1M 943,886
Accumulated Depreciation -195,834 -145,853 -106,450 -69,779 -34,316
Net PPE 4.2M 4.0M 4.0M 4.0M 909,570
Goodwill 14.0M 12.5M 11.5M 11.5M 1.9M
Goodwill And Other Intangible Assets 22.0M 19.5M 16.5M 16.6M 3.9M
Other Intangible Assets 8.0M 6.9M 5.0M 5.1M 1.9M
Total Non Current Assets 31.2M 23.4M 20.5M 20.6M 4.8M
Total Assets 39.7M 35.4M 35.4M 35.2M 32.1M
Current Debt 404,682 75,412 75,412 75,412 75,412
Current Debt And Capital Lease Obligation 493,157 151,596 150,481 149,384 148,298
Accounts Payable 2.8M 2.0M 1.4M 1.5M 492,157
Payables 2.9M 2.0M 1.6M 1.5M 492,157
Payables And Accrued Expenses 2.9M 2.0M 1.6M 1.5M 492,157
Current Liabilities 3.3M 2.1M 1.7M 1.7M 640,455
Long Term Debt 3.1M 280,500 299,353 318,206 337,059
Long Term Debt And Capital Lease Obligation 3.8M 727,303 765,631 803,693 841,437
Long Term Capital Lease Obligation 679,889 446,803 466,278 485,487 504,378
Other Non Current Liabilities -- -- -- -1,000 --
Total Non Current Liabilities Net Minority Interest 6.2M 2.8M 2.9M 2.9M 1.4M
Total Liabilities Net Minority Interest 9.5M 4.9M 4.6M 4.6M 2.0M
Common Stock 31.7M 31.7M 31.7M 31.7M 31.5M
Capital Stock 31.7M 31.7M 31.7M 31.7M 31.5M
Additional Paid In Capital 879,801 674,733 674,733 674,733 1.1M
Retained Earnings -2.6M -2.2M -1.8M -2.0M -2.8M
Common Stock Equity 30.0M 30.2M 30.6M 30.3M 29.8M
Stockholders Equity 30.0M 30.2M 30.6M 30.3M 29.8M
Total Equity Gross Minority Interest 30.2M 30.4M 30.8M 30.6M 30.1M
Minority Interest 233,336 233,213 234,869 222,483 252,432
Total Capitalization 33.1M 30.5M 30.9M 30.7M 30.2M
Net Tangible Assets 8.0M 10.7M 14.1M 13.7M 25.9M
Tangible Book Value 8.0M 10.7M 14.1M 13.7M 25.9M
Working Capital 5.1M 9.8M 13.2M 12.9M 26.7M
Invested Capital 33.5M 30.6M 31.0M 30.7M 30.2M
Total Debt 4.3M 878,899 916,112 953,077 989,735
Share Issued 117.3M 117.3M 117.3M 117.3M 117.0M
Ordinary Shares Number 117.3M 117.3M 117.3M 117.3M 117.0M
Allowance For Doubtful Accounts Receivable -- -- -- -- --
Buildings And Improvements 3.6M 3.4M 3.4M 3.4M 564,675
Capital Lease Obligations 768,364 522,987 541,347 559,459 577,264
Current Capital Lease Obligation 88,475 76,184 75,069 73,972 72,886
Current Deferred Assets -- -- -- 0.00 0.00
Dueto Related Parties Current -- -- -- -- --
Gross Accounts Receivable -- -- -- -- --
Income Tax Payable -- -- -- -- --
Land And Improvements 270,275 270,275 270,275 270,275 --
Leases 309,067 309,067 309,067 309,067 309,067
Machinery Furniture Equipment 255,221 174,328 154,350 127,447 70,144
Non Current Deferred Liabilities 2.3M 2.1M 2.1M 2.1M 527,856
Non Current Deferred Taxes Liabilities 2.3M 2.1M 2.1M 2.1M 527,856
Non Current Prepaid Assets 5.0M -- -- -- --
Other Current Borrowings 404,682 75,412 75,412 75,412 75,412
Other Inventories 2.4M -- -- 1.3M --
Properties 0.00 0.00 0.00 0.00 0.00
Raw Materials 53,321 -- -- 44,254 --
Taxes Receivable -- -- -- -- 228.00
Total Tax Payable 10,954 20,766 152,492 10,521 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow 550,259 -186,826 129,534 1.1M -642,898
Cash Flow From Continuing Operating Activities 550,259 -186,826 129,534 1.1M -642,899
Depreciation And Amortization 222,331 188,639 187,459 191,563 75,883
Depreciation Amortization Depletion 222,331 188,639 187,459 191,563 75,883
Stock Based Compensation -- -- -- -448,231 --
Deferred Tax -47,158 -33,600 -34,011 -127,419 -8,270
Deferred Income Tax -47,158 -33,600 -34,011 -127,419 -8,270
Change In Working Capital 559,394 30,615 -291,919 761,020 -477,927
Changes In Account Receivables 185,785 -270,726 -45,654 -- -96,923
Change In Receivables 185,785 -270,726 -45,654 -- -77,505
Change In Inventory -324,865 -71,043 -308,484 -- -134,062
Change In Payables And Accrued Expense 829,679 396,695 46,346 -- -223,886
Change In Payable 829,679 396,695 46,346 -- -223,886
Change In Other Working Capital -- -- -- -- 0.00
Other Non Cash Items 19,803 13,245 13,706 14,395 13,654
Capital Expenditure -- -2.1M -26,903 -- --
Purchase Of PPE 2.1M -2.1M -26,903 0.00 0.00
Net PPE Purchase And Sale 2.1M -2.1M -26,903 0.00 0.00
Purchase Of Business -10.2M -- -- -14.9M --
Investing Cash Flow -8.2M -3.1M -26,903 -14.9M -2.1M
Cash Flow From Continuing Investing Activities -8.2M -3.1M -26,903 -14.9M -2.1M
Repayment Of Debt -61,020 -50,458 -50,672 -51,053 -40,740
Net Issuance Payments Of Debt 3.1M -50,458 -50,672 -51,053 -40,740
Issuance Of Capital Stock 0.00 -- -- 0.00 7.6M
Net Common Stock Issuance 0.00 -- -- 0.00 7.6M
Financing Cash Flow 3.1M -50,458 -50,672 -51,053 7.6M
Cash Flow From Continuing Financing Activities 3.1M -50,458 -50,672 -51,053 7.6M
Changes In Cash -4.5M -3.4M 51,959 -13.8M 4.9M
Beginning Cash Position 9.6M 12.9M 12.9M 26.7M 21.8M
End Cash Position 5.0M 9.6M 12.9M 12.9M 26.7M
Free Cash Flow 2.6M -2.3M 102,631 1.1M -642,898
Amortization Cash Flow -- -- 128,343 -- 31,208
Amortization Of Intangibles -- -- 128,343 -- 31,208
Change In Account Payable 829,679 528,421 -95,625 -- -96,340
Change In Income Tax Payable 0.00 -131,726 141,971 -- -9,300
Change In Prepaid Assets -131,205 -24,311 15,873 -- -42,474
Change In Tax Payable 0.00 -131,726 141,971 -- -9,300
Common Stock Issuance 0.00 -- -- 0.00 7.6M
Depreciation -- -- 59,116 -- 44,675
Long Term Debt Payments -61,020 -50,458 -50,672 -51,053 -40,740
Net Business Purchase And Sale -10.2M -- -- -14.9M -2.1M
Net Income From Continuing Operations -409,179 -385,725 254,299 723,233 -977,623
Net Long Term Debt Issuance 3.1M -50,458 -50,672 -51,053 -40,740
Proceeds From Stock Option Exercised 0.00 -- -- 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...